Valhi (VHI) Q2 2026 earnings review
Restructuring and Volume Recovery Drive Massive Earnings Rebound
Valhi delivered a breakout quarter, proving its late-2025 restructuring is bearing fruit. Total revenue accelerated to 12% YoY growth, reaching $606.1M, as end-market demand rebounded. More importantly, operating leverage returned with a vengeance: total operating margin expanded to 11.2%, up from a trough of -6.2% just two quarters ago. Consequently, EPS surged to $0.78, completely reversing the heavy losses from the second half of 2025 and signaling the company's turnaround is firmly on track.
🐂 Bull Case
Chemicals operating margins are rapidly expanding as the Q4 2025 restructuring, higher plant utilization, and lower raw material costs dramatically lower the segment's cost profile.
Volumes are accelerating (+16% YoY in TiO2) as market share gains compound with improving end-market demand, driving top-line outperformance.
🐻 Bear Case
Pricing power remains negative (-3% YoY), forcing the company to rely entirely on volume and internal cost cuts for margin growth rather than pricing leverage.
Real Estate development is slowing. A 23% drop in land sales was masked this quarter by a one-time $5.8M gain on the sale of an office building.
⚖️ Verdict: 🟢
Bullish. Management successfully navigated the 2025 industry downturn. The combination of permanently lower fixed costs and accelerating volume positions the company for significant earnings growth, especially if the newly announced price increases gain traction.
Key Themes
Cost Reductions Fuel Chemicals Turnaround
The Chemicals segment executed a textbook turnaround, with operating income swinging from a massive $60.1M loss in 25Q4 to a $40.4M profit this quarter. This reversal was driven by the aggressive cost-reduction initiatives implemented in Q4 2025, lower unabsorbed fixed costs due to higher plant utilization, and lower raw material (feedstock) costs. Operating margins for the segment expanded to 7.2%, proving the new cost structure works.
TiO2 Volume Surge Accelerates
Chemicals volumes accelerated dramatically, growing 16% YoY in Q2—a steep acceleration from 4% growth in Q1 and contractions throughout mid-2025. Management cited broad-based market share gains across all markets. This volume surge was the primary engine behind the segment's revenue growth, successfully masking the lingering weakness in average selling prices.
Pricing Power Remains Elusive
Despite the 16% surge in volumes and management's claim that prices rose 4% sequentially during H1, YoY pricing power remains negative. Lower average TiO2 selling prices dragged net sales down by 3% in Q2. This directly contradicts the bull narrative of a full market recovery; the company is still relying entirely on volume and cost-cutting for profit growth. Management announced price increases and surcharges during Q2, but market acceptance remains unproven.
Currency and Macro Headwinds
While internal operations improved significantly, the macroeconomic picture continues to act as a drag. Fluctuations in currency exchange rates, primarily the Euro, reduced the Chemicals segment's operating income by approximately $12M in the quarter and $18M for the first six months. This highlights the vulnerability of the segment's recovery to global economic conditions outside management's control.
Security and Marine Products Drive Component Growth
The Component Products segment continues to be a quiet but highly profitable growth engine. Sales grew 8% YoY, specifically driven by targeted security products across the healthcare, transportation, and tool storage markets, as well as marine components sold to industrial markets. This specific product focus allowed the segment to expand its operating margin to an impressive 20.4%, up from 15.6% a year ago.
Real Estate Earnings Cliff
The Real Estate segment's core operations are winding down. Net sales fell 23% YoY as development activity for previously sold residential parcels slowed. While the segment reported a healthy $18.4M in operating income, this was heavily inflated by a one-time $5.8M gain on the sale of an office building. As the planned community nears completion, this segment will cease to be a meaningful contributor to the bottom line.
Other KPIs
Accelerating. Up 91% YoY from $35.5M in 25Q2, representing the strongest operational performance in over a year. The massive beat was entirely driven by the Chemicals segment turnaround and margin expansion in Component Products, easily absorbing a $12M currency headwind.
Stable. Corporate expenses decreased by 2% YoY, primarily due to lower environmental remediation and related costs, showing strong cost discipline at the holding company level.
Key Questions
Price Increase Acceptance
How much of the recently announced TiO2 price increases and surcharges have actually been accepted by customers, and when will they be fully reflected in the P&L?
Normalized Margins
What is the expected normalized run-rate for the Chemicals segment's operating margin now that the Q4 2025 cost initiatives are fully implemented and volumes have rebounded?
Real Estate Strategy
With Real Estate development activities winding down and the office building sold, what is the strategic plan and expected cash flow profile for this segment over the next 12-24 months?